Floatz logo

LIDOCAINE

Chronic Low Back Pain (CLBP)

Peking University Third HospitalSmall moleculeActive
D
30/ 100
Provisional rating · Methodology v0.2

Rating breakdown

Clinical Evidence
15/ 100
Competitive Position
81/ 100

Competitive context

4 Active assets in the Chronic Low Back Pain (CLBP) cohort.

Asset / SponsorPhaseRating
Naproxen
Iffat Anwar Medical Complex
N/AD
DEXAMETHASONE
Peking University Third Hospital
D
DICLOFENAC
Iffat Anwar Medical Complex
N/AD
IBUPROFEN
Iffat Anwar Medical Complex
N/AD

Same molecule, other indications

LIDOCAINE is also rated in:

peripheral neuropathyDormant
BBB
Indicative ·
79 / 100
View asset →
postherpetic neuralgiaDormant
BBB
Indicative ·
78 / 100
View asset →
post-operative pain, non-human animalDormant
BBB
Indicative ·
76 / 100
View asset →

Need depth?

Order a full diligence report on this asset.

Order report →

Are you the sponsor?

Submit your data room for a Verified Rating. The public-data rating remains visible alongside.

Contact →